Investment Stage

Focus Areas

About Investor

Guillaume Baxter is a Partner at Sofinnova Partners (Industrial Biotech Strategy) in Paris, backing industrial biotechnology and renewable chemistry where biotech rewires industries like agriculture, food, chemicals, and materials. Sofinnova frames this strategy as early-stage and sustainability-driven, and the firm has described initial ticket sizes around ~€1M to ~€8M (with strong capacity to follow on). Before Sofinnova, he spent several years at Solvay in Brussels developing sustainable tech via partnerships, then moved to Solvay Ventures as an Investment Manager, and joined Sofinnova in 2017.